Afuco™ Anti-Human PDGFD ADCC Therapeutic Antibody, ADCC Enhanced
Anti-PDGFD ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies bind to zvegf4. The antibodies may be polyclonal, monoclonal, murine, humanized or neutralizing. They are useful in the treatment of inter alia, fibroproliferative disorders of the kidney, liver, and bone.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-722CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | PDGFD |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |